BLTE
Belite Bio Inc

262
Mkt Cap
$6.6B
Volume
116,071.00
52W High
$200.00
52W Low
$49.00
PE Ratio
-98.58
BLTE Fundamentals
Price
$186.15
Prev Close
$189.26
Open
$188.00
50D MA
$164.16
Beta
0.56
Avg. Volume
253,581.55
EPS (Annual)
-$1.18
P/B
24.09
Rev/Employee
$0.00
$1,782.36
Loading...
Loading...
News
all
press releases
Belite Bio (NASDAQ:BLTE) Shares Gap Up - Still a Buy?
Belite Bio (NASDAQ:BLTE) Shares Gap Up - What's Next...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the...
MarketBeat·10d ago
News Placeholder
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Short Interest Up 49.4% in January
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) saw a significant increase in short interest in the month of January. As of January 30th, there was short interest totaling 585,301...
MarketBeat·11d ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Shares Down 5.2% - Here's Why
Belite Bio (NASDAQ:BLTE) Stock Price Down 5.2% - Time to Sell...
MarketBeat·15d ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Reaches New 12-Month High - Here's What Happened
Belite Bio (NASDAQ:BLTE) Reaches New 1-Year High - Here's What Happened...
MarketBeat·22d ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Reaches New 1-Year High - Still a Buy?
Belite Bio (NASDAQ:BLTE) Hits New 12-Month High - Time to Buy...
MarketBeat·29d ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Now Covered by Bank of America
Bank of America assumed coverage on shares of Belite Bio in a research report on Monday. They set a "buy" rating and a $195.00 price objective for the company...
MarketBeat·30d ago
News Placeholder
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Belite Bio, Inc. Sponsored ADR (NASDAQ:BLTE - Get Free Report) has been given an average rating of "Moderate Buy" by the seven brokerages that are covering the firm, Marketbeat reports. One...
MarketBeat·1mo ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Reaches New 1-Year High - Here's Why
Belite Bio (NASDAQ:BLTE) Reaches New 1-Year High - What's Next...
MarketBeat·2mo ago
News Placeholder
Belite Bio (NASDAQ:BLTE) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut Belite Bio from a "hold" rating to a "sell" rating in a research note on Sunday...
MarketBeat·2mo ago
<
1
2
...
>

Latest BLTE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.